Table 2

Paired median patient prices, originator and biosimilar insulin, 1000 IU in US dollars

Insulin typeVialCartridge
SurveyOriginator brand (OB)Biosimilar (BS)Difference
BS to OB
SurveyOBBSDifference
BS to OB
Public sector
 Short-acting humanGH$12.25 S (1)$9.05 Bc (1)26% ↓CH$28.47 L, N (3)$25.44 D (1)11% ↓
RU$7.03 L, N (5)$6.53 Ge, P (2)7% ↓CS$32.61 L, N (2)$28.98 D (2)11% ↓
RU$11.28 L, N, S (6)$9.87 Bt, Ge, M, P (2)13% ↓
 Intermediate-acting humanRU$7.03 N (5)$5.67 P (2)19% ↓RU$10.60 L, N, S (3)$9.72 Bt, Ge, M, P (2)8% ↓
CS$34.55 N (2)$28.98 D (1)16% ↓
 30/70 humanET$3.15 N (1)$3.26 J (1)3% ↑CH$28.26 L, N (3)$27.62 Bt, D, Li (2)2% ↓
GH$9.76 S (1)$9.05 Bc (1)7% ↓CS$32.63 L, N (3)$28.98 D (1)11% ↓
RU$11.48 L (2)$10.17 Bt, M (2)11% ↓
 Glargine analogueCS$122.16 S (1)$91.75 GL (3)25% ↓
Private retail pharmacies
 Short-acting humanET$5.90 N, S (7)$3.98 J (1)32% ↓RU$10.98 L, N, S (7)$11.14 Ge, P (6)1% ↑
IH$5.56 L, N (9)$5.56 W (1)0%CS$30.23 N (8)$24.74 D (5)18% ↓
IP$5.63 L, N (13)$5.69 Bc (1)1% ↑
PK$5.81 L, N, S (18)$4.50 G, H, Pe (13)23% ↓
RU$6.89 L, N, S (9)$8.67 Ge, P (7)26% ↑
 Intermediate-acting humanBR$14.97 N, L (9)$14.46 Bc (1)3% ↓RU$9.98 L, N, S (5)$11.50 Ge, P (5)15% ↑
ET$5.42 N, S (13)$4.01 D, J (6)26% ↓CS$30.31 N (7)$25.21 D (2)17% ↓
PK$5.81 L, N, S (18)$4.67 G, H, Pe (8)20% ↓
RU$6.97 N, S (6)$8.78 Ge, P (5)26% ↑
 30/70 humanET$5.42 N, S (7)$2.97 J (2)45% ↓CH$29.87 L, N (5)$54.60 D, Li (2)83% ↑
UG$7.05 L, N (9)$4.70 W (1)33% ↓PK$5.82 L, N (2)$7.89 G (1)36% ↑
GH$14.22 L, N, S (7)$11.12 Bc (1)22% ↓CS$30.27 L, N (10)$27.04 D, U (8)11% ↓
IH$5.55 L, N (13)$5.56 Bc, W (4)0%
IP$5.62 L, N (15)$6.00 Bc, W (9)7% ↑
PK$5.15 L, N (20)$4.48 G, H, Pe (12)13% ↓
 Glargine analogueUG$44.07 S (1)$36.72 Bc (2)17% ↓IP$27.29 S (1)$23.12 Bc (2)15% ↓
PK$28.60 S (8)$20.65 G (4)28% ↓CS$121.13 S (4)$89.69 GL (4)26% ↓
Private hospital/clinics
 Short-acting humanIP$5.59 L, N (3)$5.59 Sh (1)0%
PK$5.81 L, S (4)$4.72 G (1)19% ↓
 Intermediate-acting humanET$5.38 N, S (2)$3.25 J (1)40% ↓
 30/70 humanIP$5.65 L, N (3)$6.00 Bc, Sh, W (3)6% ↑CH$33.09 L, N (2)$31.81 Bt, D (1)4% ↓
PK$5.15 L, N, S (4)$4.48 G (1)13% ↓IP$12.21 L (1)$7.54 Bc (2)38% ↓
CS$32.63 L, N (3)$29.17 D, U (2)11% ↓
 Glargine analogueKE$61.89 S (1)$38.70 Bc (1)37% ↓
  • Number in brackets=number of outlets where found.

  • Country surveys: CH, Hubei, China; CS, Shaanxi, China; ET, Ethiopia; GH, Ghana; IH Haryana, India; IP, Madhya Pradesh, India; KE, Kenya; PK, Pakistan; RU, Kazan, Russia; UG, Uganda.

  • Originator companies: L, Lilly; N, Novo Nordisk; S, Sanofi.

  • Biosimilar companies: Bc, Biocon; Bt, Bioton; D, Tonghua Dongbao; G, Getz; Ge, Geropharm; GL, Gan&Lee; H, Highnoon; J, Julphar; Li, Lianbang; M, Medsintez; P, Pharmstandard; Pe, PharmEvo; Sh, Shreya; U, United; W, Wockhardt.